Condition: Castration-resistant Prostate Cancer · Sponsor: European Institute of Oncology
This study is aimed to compare whole body MRI (WB-MRI) with Bone Scintigraphy (BS) and Computerized Tomography (CT) scans in patients receiving treatment for metastatic castration-resistant prostate cancer to the bone. This is a monocentric, prospective observational study.
This description comes directly from the study's public registry record.
Giuseppe Petralia, MD · +39 02 9437 2901 · giuseppe.petralia@ieo.it
Always discuss trial participation with your own doctor first.
| IEO Istituto Europeo di Oncologia | Milan, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06321679